Related references
Note: Only part of the references are listed.Global Cancer Incidence and Mortality Rates and Trends-An Update
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Genomic Landscape of Colorectal Mucosa and Adenomas
Ester Borras et al.
CANCER PREVENTION RESEARCH (2016)
Chemoprevention of familial adenomatous polyposis
Patrick M. Lynch
FAMILIAL CANCER (2016)
Development of a murine colonoscopic polypectomy model (with videos)
Furkan Ertem et al.
GASTROINTESTINAL ENDOSCOPY (2016)
Tolfenamic acid downregulates β-catenin in colon cancer
Taekyu Ha et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Chemoprevention of hereditary colon cancers: time for new strategies
Luigi Ricciardiello et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
SARTools: A DESeq2-and EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data
Hugo Varet et al.
PLOS ONE (2016)
Sulindac, 3,3′-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis
Angelo Pietro Femia et al.
BMC CANCER (2015)
Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells
Monica Cojoc et al.
CANCER RESEARCH (2015)
A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations
Michael Buchert et al.
DISEASE MODELS & MECHANISMS (2015)
Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15
Vita Golubovskaya et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer
Maureen E. Mork et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon
Praveen Rajendran et al.
CLINICAL EPIGENETICS (2015)
Multiple mucin depleted foci, high proliferation and low apoptotic response in the onset of colon carcinogenesis of the PIRC rat, mutated in Apc
Angelo Pietro Femia et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Anti-tumor activity of non-steroidal anti-inflammatory drugs: Cyclooxygenase-independent targets
Jason L. Liggett et al.
CANCER LETTERS (2014)
Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal
Deqiang Sun et al.
CELL STEM CELL (2014)
The utility of Apc-mutant rats in modeling human colon cancer
Amy A. Irving et al.
DISEASE MODELS & MECHANISMS (2014)
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
M. J. Duffy et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Tolfenamic Acid Inhibits Colon Cancer Cell and Tumor Growth and Induces Degradation of Specificity Protein (Sp) Transcription Factors
Satya Pathi et al.
MOLECULAR CARCINOGENESIS (2014)
Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention
Laura M. Beaver et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
miR-125a/b Regulates the Activation of Cancer Stem Cells in Paclitaxel-resistant Colon Cancer
Jixiang Chen et al.
CANCER INVESTIGATION (2013)
The Involvement of Endoplasmic Reticulum Stress in the Suppression of Colorectal Tumorigenesis by Tolfenamic Acid
Xiaobo Zhang et al.
CANCER PREVENTION RESEARCH (2013)
HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates
Praveen Rajendran et al.
EPIGENETICS (2013)
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors
Gayathri Chadalapaka et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer
Rong Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial
Bjorn W. H. van Heumen et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
S100A8 and S100A9 Are Associated with Colorectal Carcinoma Progression and Contribute to Colorectal Carcinoma Cell Survival and Migration via Wnt/β-Catenin Pathway
Liang Duan et al.
PLOS ONE (2013)
WIF1 causes dysfunction of heart in transgenic mice
Dan Lu et al.
TRANSGENIC RESEARCH (2013)
Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence
Armin Gerger et al.
CLINICAL CANCER RESEARCH (2011)
NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
Rong Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
β-catenin as a potential key target for tumor suppression
Yuejun Fu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly
Praveen Rajendran et al.
MOLECULAR CANCER (2011)
Metabolic Targets of Cardiac Hormones' Therapeutic Anti-Cancer Effects
David L. Vesely
CURRENT PHARMACEUTICAL DESIGN (2010)
Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma
Liang Zhao et al.
FEBS JOURNAL (2010)
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression
Santhi Konduri et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and β-catenin expression in the rat
Rong Wang et al.
CARCINOGENESIS (2008)
Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention
Hang Xiao et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer
James M. Amos-Landgraf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase
MC Myzak et al.
CANCER RESEARCH (2004)
Share Paper
